SlideShare a Scribd company logo
1 of 22
Download to read offline
ORGANOPHOSPHATE
POISONING
T. SOUJANYA
PHARM. D
CONTENT:
Introduction
Usual fatal dose
Mechanism of action
Toxicokinetics
Clinical (toxic) symptoms
Diagnosis
Management
Reference/Bibliography
INTRODUCTION:
Organophosphates are among the
most popular and most widely used
insecticides in India.
These compounds are available as
dusts, granules, or liquids.
Some products need to be diluted
with water before use, and some are
burnt to make smoke that kills
insects.
USUAL FATAL DOSE:
Toxicity Rating:
The following compounds are extremely toxic (LD50: 1 to 50 mg/kg), or
highly toxic (LD50: 51 to 500 mg/kg):
Chlorfenvinphos, Chlorpyriphos, Demeton, Diazinon, Dichlorvos, Dimethoate,
Disulfoton, Ediphenphos, Ethion, Fenitrothion, Fensulfothion, Fenthion,
Fonophos, Formothion, Methyl Parathion, Mevinphos, Monocrotophos,
Oxydemeton Methyl, Phenthoate, Phorate, Phosphamidon, Quinalphos, TEPP,
and Thiometon.
CONTD…
The following compounds are moderately toxic (LD50:501 to 5000 mg/kg), or
slightly toxic (LD50: more than 5000mg/kg):
Abate, Acephate, Coumaphos, Crufomate, Famphur, Glyphosate, Malathion,
Phenthoate, Primiphos Methyl, Ronnel, Temephos, Triazophos, and
Trichlorphon.
Even in cases where treatment was begun early with atropine and oximes,
mortality in organophosphate poisoning is generally to the extent of 7 to 12%.
MECHANISM OF ACTION:
Organophosphates are powerful inhibitors of acetylcholinesterase which is
responsible for hydrolyzing acetylcholine to choline and acetic acid after its
release and completion of function (i.e. propagation of action potential).
As a result, there is accumulation of acetylcholine with continued stimulation
of local receptors and eventual paralysis of nerve or muscle.
Acetylcholine choline + acetic acid
Acetyl cholinesterase
Organophosphates
Organophosphate compounds
Inhibits acetylcholinesterase
by phosphorylation
Accumulation of acetylcholine
Central nervous
system
Peripheral nervous
system
Neuromuscular
junction
Neuromuscular junction
Clinical manifestations
Initial cholinergic
crisis
Intermediate
syndrome
Delayed syndrome
TOXICOKINETICS:
Organophosphates can be absorbed by any route including transdermal,
transconjunctival, inhalational, across the GI and GU mucosa, and through
direct injection.
Manifestations usually begin within a few minutes to few hours, but may be
delayed upto 12 hours or more in the case of certain compounds (e.g. fenthion,
parathion).
CLINICAL (TOXIC) SYMPTOMS:
1. ACUTE POISONING:
a) Cholinergic Excess:
Muscarinic Effects (hollow organ parasympathetic manifestations):
Common manifestations include bronchoconstriction with wheezing and
dyspnea, cough, pulmonary oedema, vomiting, diarrhoea, abdominal cramps,
increased salivation, lacrimation, and sweating, bradycardia, hypotension,
miosis, and urinary incontinence.
Some of these can be remembered by the acronym:
SLUDGE: Salivation, Lacrimation, Urination, Diarrhoea, Gastrointestinal
distress and Emesis.
CONTD…
Nicotinic Effects (autonomic ganglionic and somatic motor effects):
Fasciculations, weakness, hypertension, tachycardia, and paralysis. Muscle
weakness, fatiguability, and fasciculations are very common. Hypertension can
occur in up to 20 per cent of patients. Tachycardia is also common.
b) CNS Effects:
Restlessness, headache, tremor, drowsiness, delirium, slurred speech,
ataxia, and convulsions. Coma supervenes in the later stages.
CONTD…
2. CHRONIC POISONING:
It usually occurs as an occupational hazard in agriculturists, especially
those who are engaged in pesticide spraying of crops. Route of exposure is
usually inhalation or contamination of skin. The following are the main features:
a. Polyneuropathy: paraesthesias, muscle cramps, weakness, gait disorders.
b. CNS Effects: drowsiness, confusion, irritability, anxiety.
c. Sheep Farmer’s Disease: psychiatric manifestations encountered in sheep
farmers involved in long-term sheep-dip operations.
DIAGNOSIS:
1. Depression of cholinesterase activity:
a) If the RBC cholinesterase level is less than 50% of normal.
b) Depression of plasma cholinesterase level (to less than 50%).
2. P-Nitrophenol Test.
3. Thin Layer Chromatography (TLC).
4. High performance thin layer chromatography (HPLC).
MANAGEMENT:
1. ACUTE POISONING:
a. Decontamination:
If skin spillage has occurred, it is imperative that the patient be stripped and
washed thoroughly with soap and water.
Shower is preferable. Make the patient stand (if he is able to) under the
shower, or seated in a chair.
Wash with cold water for 5 minutes from head to toe using non-germicidal
soap. Rinse hair well.
Repeat the wash and rinse procedure with warm water.
CONTD…
Repeat the wash and rinse procedure with hot water.
Treating personnel should protect themselves with water-impermeable gowns,
masks with eye shields, and shoe covers. Latex and vinyl gloves provide
inadequate protection, unless a double pair is used.
If ocular exposure has occurred, copious eye irrigation should be done with
normal saline or Ringer’s solution. If these are not immediately available, tap
water can be used.
In the case of ingestion, stomach wash can be done, though this is often
unnecessary because the patient would have usually vomited several times by
the time he is brought to hospital. Activated charcoal can be administered in
the usual way.
CONTD…
b. Antidotes:
i) Atropine:
Mode of action: It is a competitive antagonist of acetylcholine at the
muscarinic postsynaptic membrane and in the CNS, and blocks the muscarinic
manifestations of organophosphate poisoning.
Diagnostic dose: Adult - 1 mg intravenously or intramuscularly; Child - 0.25
mg (about 0.01 mg/kg) intravenously or intramuscularly.
Therapeutic dose: 1 to 2 mg IV or IM (adult); 0.05 mg/kg IV (child); every 15
minutes until the endpoint is reached, i.e. drying up of tracheobronchial
secretions. Pupillary dilatation and tachycardia are not reliable indicators of the
endpoint.
CONTD…
ii) Pralidoxime (Pyridine-2-aldoxime methiodide; 2-PAM)
Mode of action: It is usually given along with atropine. Pralidoxime competes
for the phosphate moiety of the organophosphorus compound and releases it
from the acetylcholinesterase enzyme, thereby liberating the latter and
reactivating it.
Dose: For adults: 1 to 2 gm in 100 to 150 ml of 0.9% sodium chloride, given
IV over 30 minutes. This can be repeated after 1 hour, and subsequently every
6 to 12 hours, for 24 to 48 hours.
For children: 20 to 40 mg/kg to a maximum of 1 gm/dose given IV, and
repeated every 6 to 12 hours for 24 to 48 hours. Alternatively, iv infusion can
be resorted to, at a rate of 9 to 19 mg/kg/hr.
CONTD…
iii) Diazepam
Some studies indicate that the addition of diazepam to atropine and 2-PAM
improves survival. it reduces the risk of seizure-induced brain and cardiac
damage.
Dose: For adults: 5 to 10 mg IV slowly, every 15 minutes, upto a maximum of
30 mg.
For children: 0.25 to 0.4 mg/kg IV slowly, every 5 to 10 minutes, upto a
maximum of 10 mg.
If diazepam is ineffective, phenytoin or phenobarbitone can be used instead
CONTD…
c. Supportive Measures:
Administer IV fluids to replace losses.
Maintain airway patency and oxygenation. Suction secretions. Endotracheal
intubation and mechanical ventilation may be necessary. Monitor pulse
oximetry or arterial blood gases to determine need for supplemental oxygen.
Oxygenation/intubation/positive pressure ventilation.
The following drugs are contraindicated: parasympathomimetics,
phenothiazines, antihistamines and opiates.
CONTD…
Treat convulsions with benzodiazepines or barbiturates.
Antibiotics are indicated only when there is evidence of infection.
Hemoperfusion, haemodialysis, and exchange transfusion have not been
shown to affect outcome or duration of toxicity in controlled trials of
organophosphate poisoning.
CONTD…
2. CHRONIC POISONING:
a. Removal of the patient from the source of exposure.
b. Supportive and symptomatic measures.
REFERENCE/BIBLIOGRAPHY:
V. V. Pillay - Modern medical
toxicology - 4th edition.
organophosphatepoisoning-200702052632 (2).pdf

More Related Content

Similar to organophosphatepoisoning-200702052632 (2).pdf

· IndicationsSee Pronunciation· Used systemically and locally .docx
· IndicationsSee Pronunciation· Used systemically and locally .docx· IndicationsSee Pronunciation· Used systemically and locally .docx
· IndicationsSee Pronunciation· Used systemically and locally .docx
odiliagilby
 
Antifungal Drugs
Antifungal DrugsAntifungal Drugs
Antifungal Drugs
guest151c
 
General approach and management of poisoning.pptx
General approach and management of poisoning.pptxGeneral approach and management of poisoning.pptx
General approach and management of poisoning.pptx
Ruban Raj
 
Antihelminthiasis.pptx
Antihelminthiasis.pptxAntihelminthiasis.pptx
Antihelminthiasis.pptx
Anant Khot
 

Similar to organophosphatepoisoning-200702052632 (2).pdf (20)

Op poisioning
Op poisioningOp poisioning
Op poisioning
 
· IndicationsSee Pronunciation· Used systemically and locally .docx
· IndicationsSee Pronunciation· Used systemically and locally .docx· IndicationsSee Pronunciation· Used systemically and locally .docx
· IndicationsSee Pronunciation· Used systemically and locally .docx
 
Organochlorines
OrganochlorinesOrganochlorines
Organochlorines
 
Paraquat poisoning by Dr.Jeevan Tc.pptx
Paraquat poisoning by  Dr.Jeevan Tc.pptxParaquat poisoning by  Dr.Jeevan Tc.pptx
Paraquat poisoning by Dr.Jeevan Tc.pptx
 
OPC Poisonig Slide ,Treatment and Data analysis.
OPC Poisonig Slide ,Treatment and Data analysis.OPC Poisonig Slide ,Treatment and Data analysis.
OPC Poisonig Slide ,Treatment and Data analysis.
 
Poisoning & its management
Poisoning & its managementPoisoning & its management
Poisoning & its management
 
Antifungal Drugs
Antifungal DrugsAntifungal Drugs
Antifungal Drugs
 
New drug delivery system
New drug delivery systemNew drug delivery system
New drug delivery system
 
L P 2 Cholinoergic drugs.pdf
L P 2 Cholinoergic drugs.pdfL P 2 Cholinoergic drugs.pdf
L P 2 Cholinoergic drugs.pdf
 
L P 2 Cholinoergic drugs.pdf
L P 2 Cholinoergic drugs.pdfL P 2 Cholinoergic drugs.pdf
L P 2 Cholinoergic drugs.pdf
 
Management of organophosphates poisoning.
Management of organophosphates poisoning.Management of organophosphates poisoning.
Management of organophosphates poisoning.
 
General approach and management of poisoning.pptx
General approach and management of poisoning.pptxGeneral approach and management of poisoning.pptx
General approach and management of poisoning.pptx
 
Decontamination, specific antidotes
Decontamination, specific antidotesDecontamination, specific antidotes
Decontamination, specific antidotes
 
Anticholinergics and anti emetics
Anticholinergics and anti emeticsAnticholinergics and anti emetics
Anticholinergics and anti emetics
 
Antiarrhythmic drug
Antiarrhythmic drugAntiarrhythmic drug
Antiarrhythmic drug
 
Pharmacology of cholinergic blocking drugs
Pharmacology of cholinergic blocking drugsPharmacology of cholinergic blocking drugs
Pharmacology of cholinergic blocking drugs
 
CLASS 2.pdf
CLASS 2.pdfCLASS 2.pdf
CLASS 2.pdf
 
Acute poisoning
Acute poisoningAcute poisoning
Acute poisoning
 
Organophosphate poisoning
Organophosphate poisoningOrganophosphate poisoning
Organophosphate poisoning
 
Antihelminthiasis.pptx
Antihelminthiasis.pptxAntihelminthiasis.pptx
Antihelminthiasis.pptx
 

More from DrYaqoobBahar

More from DrYaqoobBahar (20)

radiologicmimicsofcirrhosis-161222165901.pdf
radiologicmimicsofcirrhosis-161222165901.pdfradiologicmimicsofcirrhosis-161222165901.pdf
radiologicmimicsofcirrhosis-161222165901.pdf
 
usglivercirrhosis-190918135350.pdf important
usglivercirrhosis-190918135350.pdf importantusglivercirrhosis-190918135350.pdf important
usglivercirrhosis-190918135350.pdf important
 
C.08a-Diagnosis-and-Treatment-of-Acute-Ischemic-Stroke-Presentation-ppt.pptx
C.08a-Diagnosis-and-Treatment-of-Acute-Ischemic-Stroke-Presentation-ppt.pptxC.08a-Diagnosis-and-Treatment-of-Acute-Ischemic-Stroke-Presentation-ppt.pptx
C.08a-Diagnosis-and-Treatment-of-Acute-Ischemic-Stroke-Presentation-ppt.pptx
 
hepaticcoma.pdf is important for medical students
hepaticcoma.pdf is important for medical studentshepaticcoma.pdf is important for medical students
hepaticcoma.pdf is important for medical students
 
abdominaltuberculosis-181221163344.asddfpdf
abdominaltuberculosis-181221163344.asddfpdfabdominaltuberculosis-181221163344.asddfpdf
abdominaltuberculosis-181221163344.asddfpdf
 
imaginginabdominaltb-150913151714-lva1-app6891.pdf
imaginginabdominaltb-150913151714-lva1-app6891.pdfimaginginabdominaltb-150913151714-lva1-app6891.pdf
imaginginabdominaltb-150913151714-lva1-app6891.pdf
 
Diagnosis and managment of pulmonary embolism
Diagnosis and managment of pulmonary embolismDiagnosis and managment of pulmonary embolism
Diagnosis and managment of pulmonary embolism
 
peripartumcardiomyopathy-171026091036.pptx
peripartumcardiomyopathy-171026091036.pptxperipartumcardiomyopathy-171026091036.pptx
peripartumcardiomyopathy-171026091036.pptx
 
heartfailure-181102160805.pdf
heartfailure-181102160805.pdfheartfailure-181102160805.pdf
heartfailure-181102160805.pdf
 
Pulmonary edema.pptx
Pulmonary edema.pptxPulmonary edema.pptx
Pulmonary edema.pptx
 
Pulmonary edema.pptx
Pulmonary edema.pptxPulmonary edema.pptx
Pulmonary edema.pptx
 
variceal bleeding 2.pdf
variceal bleeding 2.pdfvariceal bleeding 2.pdf
variceal bleeding 2.pdf
 
Hypertensive emergency.pptx
Hypertensive emergency.pptxHypertensive emergency.pptx
Hypertensive emergency.pptx
 
Hypertensive emergency.pptx
Hypertensive emergency.pptxHypertensive emergency.pptx
Hypertensive emergency.pptx
 
myxedemacoma-181130040149.pdf
myxedemacoma-181130040149.pdfmyxedemacoma-181130040149.pdf
myxedemacoma-181130040149.pdf
 
variceal bleeding.pdf
variceal bleeding.pdfvariceal bleeding.pdf
variceal bleeding.pdf
 
livervaricealbleeding12-140113002343-phpapp02.pdf
livervaricealbleeding12-140113002343-phpapp02.pdflivervaricealbleeding12-140113002343-phpapp02.pdf
livervaricealbleeding12-140113002343-phpapp02.pdf
 
adrenalcrisis-220627010816-f7d5cddb.pdf
adrenalcrisis-220627010816-f7d5cddb.pdfadrenalcrisis-220627010816-f7d5cddb.pdf
adrenalcrisis-220627010816-f7d5cddb.pdf
 
hypertensiveemergencies-160418043048.pdf
hypertensiveemergencies-160418043048.pdfhypertensiveemergencies-160418043048.pdf
hypertensiveemergencies-160418043048.pdf
 
ild2-160503173013.pdf
ild2-160503173013.pdfild2-160503173013.pdf
ild2-160503173013.pdf
 

Recently uploaded

Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch Letter
MateoGardella
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
heathfieldcps1
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
Chris Hunter
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
QucHHunhnh
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
negromaestrong
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
QucHHunhnh
 

Recently uploaded (20)

Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch Letter
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docx
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Advance Mobile Application Development class 07
Advance Mobile Application Development class 07Advance Mobile Application Development class 07
Advance Mobile Application Development class 07
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
 

organophosphatepoisoning-200702052632 (2).pdf

  • 2. CONTENT: Introduction Usual fatal dose Mechanism of action Toxicokinetics Clinical (toxic) symptoms Diagnosis Management Reference/Bibliography
  • 3. INTRODUCTION: Organophosphates are among the most popular and most widely used insecticides in India. These compounds are available as dusts, granules, or liquids. Some products need to be diluted with water before use, and some are burnt to make smoke that kills insects.
  • 4. USUAL FATAL DOSE: Toxicity Rating: The following compounds are extremely toxic (LD50: 1 to 50 mg/kg), or highly toxic (LD50: 51 to 500 mg/kg): Chlorfenvinphos, Chlorpyriphos, Demeton, Diazinon, Dichlorvos, Dimethoate, Disulfoton, Ediphenphos, Ethion, Fenitrothion, Fensulfothion, Fenthion, Fonophos, Formothion, Methyl Parathion, Mevinphos, Monocrotophos, Oxydemeton Methyl, Phenthoate, Phorate, Phosphamidon, Quinalphos, TEPP, and Thiometon.
  • 5. CONTD… The following compounds are moderately toxic (LD50:501 to 5000 mg/kg), or slightly toxic (LD50: more than 5000mg/kg): Abate, Acephate, Coumaphos, Crufomate, Famphur, Glyphosate, Malathion, Phenthoate, Primiphos Methyl, Ronnel, Temephos, Triazophos, and Trichlorphon. Even in cases where treatment was begun early with atropine and oximes, mortality in organophosphate poisoning is generally to the extent of 7 to 12%.
  • 6. MECHANISM OF ACTION: Organophosphates are powerful inhibitors of acetylcholinesterase which is responsible for hydrolyzing acetylcholine to choline and acetic acid after its release and completion of function (i.e. propagation of action potential). As a result, there is accumulation of acetylcholine with continued stimulation of local receptors and eventual paralysis of nerve or muscle. Acetylcholine choline + acetic acid Acetyl cholinesterase Organophosphates
  • 7. Organophosphate compounds Inhibits acetylcholinesterase by phosphorylation Accumulation of acetylcholine Central nervous system Peripheral nervous system Neuromuscular junction Neuromuscular junction Clinical manifestations Initial cholinergic crisis Intermediate syndrome Delayed syndrome
  • 8. TOXICOKINETICS: Organophosphates can be absorbed by any route including transdermal, transconjunctival, inhalational, across the GI and GU mucosa, and through direct injection. Manifestations usually begin within a few minutes to few hours, but may be delayed upto 12 hours or more in the case of certain compounds (e.g. fenthion, parathion).
  • 9. CLINICAL (TOXIC) SYMPTOMS: 1. ACUTE POISONING: a) Cholinergic Excess: Muscarinic Effects (hollow organ parasympathetic manifestations): Common manifestations include bronchoconstriction with wheezing and dyspnea, cough, pulmonary oedema, vomiting, diarrhoea, abdominal cramps, increased salivation, lacrimation, and sweating, bradycardia, hypotension, miosis, and urinary incontinence. Some of these can be remembered by the acronym: SLUDGE: Salivation, Lacrimation, Urination, Diarrhoea, Gastrointestinal distress and Emesis.
  • 10. CONTD… Nicotinic Effects (autonomic ganglionic and somatic motor effects): Fasciculations, weakness, hypertension, tachycardia, and paralysis. Muscle weakness, fatiguability, and fasciculations are very common. Hypertension can occur in up to 20 per cent of patients. Tachycardia is also common. b) CNS Effects: Restlessness, headache, tremor, drowsiness, delirium, slurred speech, ataxia, and convulsions. Coma supervenes in the later stages.
  • 11. CONTD… 2. CHRONIC POISONING: It usually occurs as an occupational hazard in agriculturists, especially those who are engaged in pesticide spraying of crops. Route of exposure is usually inhalation or contamination of skin. The following are the main features: a. Polyneuropathy: paraesthesias, muscle cramps, weakness, gait disorders. b. CNS Effects: drowsiness, confusion, irritability, anxiety. c. Sheep Farmer’s Disease: psychiatric manifestations encountered in sheep farmers involved in long-term sheep-dip operations.
  • 12. DIAGNOSIS: 1. Depression of cholinesterase activity: a) If the RBC cholinesterase level is less than 50% of normal. b) Depression of plasma cholinesterase level (to less than 50%). 2. P-Nitrophenol Test. 3. Thin Layer Chromatography (TLC). 4. High performance thin layer chromatography (HPLC).
  • 13. MANAGEMENT: 1. ACUTE POISONING: a. Decontamination: If skin spillage has occurred, it is imperative that the patient be stripped and washed thoroughly with soap and water. Shower is preferable. Make the patient stand (if he is able to) under the shower, or seated in a chair. Wash with cold water for 5 minutes from head to toe using non-germicidal soap. Rinse hair well. Repeat the wash and rinse procedure with warm water.
  • 14. CONTD… Repeat the wash and rinse procedure with hot water. Treating personnel should protect themselves with water-impermeable gowns, masks with eye shields, and shoe covers. Latex and vinyl gloves provide inadequate protection, unless a double pair is used. If ocular exposure has occurred, copious eye irrigation should be done with normal saline or Ringer’s solution. If these are not immediately available, tap water can be used. In the case of ingestion, stomach wash can be done, though this is often unnecessary because the patient would have usually vomited several times by the time he is brought to hospital. Activated charcoal can be administered in the usual way.
  • 15. CONTD… b. Antidotes: i) Atropine: Mode of action: It is a competitive antagonist of acetylcholine at the muscarinic postsynaptic membrane and in the CNS, and blocks the muscarinic manifestations of organophosphate poisoning. Diagnostic dose: Adult - 1 mg intravenously or intramuscularly; Child - 0.25 mg (about 0.01 mg/kg) intravenously or intramuscularly. Therapeutic dose: 1 to 2 mg IV or IM (adult); 0.05 mg/kg IV (child); every 15 minutes until the endpoint is reached, i.e. drying up of tracheobronchial secretions. Pupillary dilatation and tachycardia are not reliable indicators of the endpoint.
  • 16. CONTD… ii) Pralidoxime (Pyridine-2-aldoxime methiodide; 2-PAM) Mode of action: It is usually given along with atropine. Pralidoxime competes for the phosphate moiety of the organophosphorus compound and releases it from the acetylcholinesterase enzyme, thereby liberating the latter and reactivating it. Dose: For adults: 1 to 2 gm in 100 to 150 ml of 0.9% sodium chloride, given IV over 30 minutes. This can be repeated after 1 hour, and subsequently every 6 to 12 hours, for 24 to 48 hours. For children: 20 to 40 mg/kg to a maximum of 1 gm/dose given IV, and repeated every 6 to 12 hours for 24 to 48 hours. Alternatively, iv infusion can be resorted to, at a rate of 9 to 19 mg/kg/hr.
  • 17. CONTD… iii) Diazepam Some studies indicate that the addition of diazepam to atropine and 2-PAM improves survival. it reduces the risk of seizure-induced brain and cardiac damage. Dose: For adults: 5 to 10 mg IV slowly, every 15 minutes, upto a maximum of 30 mg. For children: 0.25 to 0.4 mg/kg IV slowly, every 5 to 10 minutes, upto a maximum of 10 mg. If diazepam is ineffective, phenytoin or phenobarbitone can be used instead
  • 18. CONTD… c. Supportive Measures: Administer IV fluids to replace losses. Maintain airway patency and oxygenation. Suction secretions. Endotracheal intubation and mechanical ventilation may be necessary. Monitor pulse oximetry or arterial blood gases to determine need for supplemental oxygen. Oxygenation/intubation/positive pressure ventilation. The following drugs are contraindicated: parasympathomimetics, phenothiazines, antihistamines and opiates.
  • 19. CONTD… Treat convulsions with benzodiazepines or barbiturates. Antibiotics are indicated only when there is evidence of infection. Hemoperfusion, haemodialysis, and exchange transfusion have not been shown to affect outcome or duration of toxicity in controlled trials of organophosphate poisoning.
  • 20. CONTD… 2. CHRONIC POISONING: a. Removal of the patient from the source of exposure. b. Supportive and symptomatic measures.
  • 21. REFERENCE/BIBLIOGRAPHY: V. V. Pillay - Modern medical toxicology - 4th edition.